| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical Outcomes After Unrestricted Implantation of Everolimus-Eluting Stents
|
Latib, Azeem
|
|
2009
|
2 |
12 |
p. 1219-1226
8 p.
|
artikel
|
| 2 |
Drug-Eluting Stents
|
Garg, Sunil
|
|
2009
|
2 |
12 |
p. 1188-1189
2 p.
|
artikel
|
| 3 |
Evaluation in 3 Months Duration of Neointimal Coverage After Zotarolimus-Eluting Stent Implantation by Optical Coherence Tomography
|
Kim, Jung-Sun
|
|
2009
|
2 |
12 |
p. 1240-1247
8 p.
|
artikel
|
| 4 |
Gone But Not Forgotten
|
Tcheng, James E.
|
|
2009
|
2 |
12 |
p. 1266-1268
3 p.
|
artikel
|
| 5 |
Guidelines: When the Doctor Becomes the Patient Things Never Seem to Fit
|
King III, Spencer B.
|
|
2009
|
2 |
12 |
p. 1290-1291
2 p.
|
artikel
|
| 6 |
Identifying the “Optimal” Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Revascularization
|
Kandzari, David E.
|
|
2009
|
2 |
12 |
p. 1279-1285
7 p.
|
artikel
|
| 7 |
Impact of Post-Intervention Minimal Stent Area on 9-Month Follow-Up Patency of Paclitaxel-Eluting Stents
|
Doi, Hiroshi
|
|
2009
|
2 |
12 |
p. 1269-1275
7 p.
|
artikel
|
| 8 |
Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions
|
Leon, Martin B.
|
|
2009
|
2 |
12 |
p. 1208-1218
11 p.
|
artikel
|
| 9 |
Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent
|
Eisenstein, Eric L.
|
|
2009
|
2 |
12 |
p. 1178-1187
10 p.
|
artikel
|
| 10 |
Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent
|
Eisenstein, Eric L.
|
|
2009
|
2 |
12 |
p. 1199-1207
9 p.
|
artikel
|
| 11 |
Long-Term Safety and Efficacy With Paclitaxel-Eluting Stents
|
Ellis, Stephen G.
|
|
2009
|
2 |
12 |
p. 1248-1259
12 p.
|
artikel
|
| 12 |
Progression of Late Stent Malapposition Beyond 2 Years After Sirolimus-Eluting Stent Implantation
|
Ueno, Koji
|
|
2009
|
2 |
12 |
p. 1288-1289
2 p.
|
artikel
|
| 13 |
Safety and Effectiveness of the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice
|
Lotan, Chaim
|
|
2009
|
2 |
12 |
p. 1227-1235
9 p.
|
artikel
|
| 14 |
Second-Generation Drug-Eluting Stents and the Continuous Need for Rapidly Available Real-World Data ⁎ ⁎ Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.
|
Mukherjee, Debabrata
|
|
2009
|
2 |
12 |
p. 1236-1239
4 p.
|
artikel
|
| 15 |
Stent Expansion as a Mechanical Parameter to Predict Late Stent Patency
|
Honda, Yasuhiro
|
|
2009
|
2 |
12 |
p. 1276-1278
3 p.
|
artikel
|
| 16 |
The First-Generation Drug-Eluting Stents and Coronary Endothelial Dysfunction
|
Pendyala, Lakshmana K.
|
|
2009
|
2 |
12 |
p. 1169-1177
9 p.
|
artikel
|
| 17 |
Two Cases of Coronary Stent Thrombosis Very Late After Bare-Metal Stenting
|
Takano, Masamichi
|
|
2009
|
2 |
12 |
p. 1286-1287
2 p.
|
artikel
|
| 18 |
3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions
|
Garg, Scot
|
|
2009
|
2 |
12 |
p. 1190-1198
9 p.
|
artikel
|
| 19 |
3-Year Clinical Outcome of Patients With Chronic Total Occlusion Treated With Drug-Eluting Stents
|
De Felice, Francesco
|
|
2009
|
2 |
12 |
p. 1260-1265
6 p.
|
artikel
|
Tijdschrift beschrijving